Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
about
Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathyVentricular arrhythmias in congestive heart failure: clinical significance and managementAssessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy.Symptoms preceding sudden cardiac death in the young are common but often misinterpreted.Hypertrophic cardiomyopathy: an important cause of sudden death.Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathyAutonomic function in hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy in the elderly.Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy: infants, children, and adolescents.Sudden death from cardiovascular disease in young athletes: fact or fiction?Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study.Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.Community study of the causes of "natural" sudden deathMicrovascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.Arrhythmias in dilated cardiomyopathy.Cardiac arrhythmias in hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy: a common disease with a good prognosis. Five year experience of a district general hospital.Relation between left ventricular gradient and relative stroke volume ejected in early and late systole in hypertrophic cardiomyopathy. Assessment with radionuclide cineangiographyImproved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardiaClinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.Problems in diagnosis and management of hypertrophic cardiomyopathy.Device therapy in hypertrophic cardiomyopathy.Low dialysate potassium concentration: an overrated risk factor for cardiac arrhythmia?Potentially lethal ventricular arrhythmias: from mundane to esoteric.Low-dose amiodarone for the treatment of arrhythmias in hypertrophic cardiomyopathy.Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy.The frontiers of cardiomyopathy.Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardiaClinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm.Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment.Electrophysiological investigation of patients with hypertrophic cardiomyopathy. Evidence that slowed intraventricular conduction is associated with an increased risk of sudden deathCalcium-Dependent Arrhythmogenic Foci Created by Weakly Coupled Myocytes in the Failing Heart.Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
P2860
Q28366841-2956CDD8-1336-4873-9BDB-5CEACAF14B3BQ33144673-1918154D-0F8A-417C-9CEB-1C6211A2CCE1Q33151284-C0324A86-6859-4115-B434-AFA03DADA5A9Q33153050-A1E3A828-7C5F-4DE5-A982-C4439723C9EBQ33172595-6CC2A307-F786-441E-A91E-4B8D5D411615Q33173891-01C0D65F-1659-483C-BB47-FD235DCF4B27Q33174392-DC570A24-4EE8-4720-89EB-D97677F00E52Q33610816-29DAA4F3-3BA7-41B1-BD7F-6E0BB41A6C73Q34028344-639C827E-0BBB-4212-981F-31E15AF3EF7FQ34244943-E3770AA3-DE6E-436F-9C27-405BA12E0527Q34265751-CCAB1D7E-7C71-4ACD-8314-8436F1F750BCQ35367410-B04561B8-2E80-4E6D-86D6-FD69A04404DDQ35478355-0030657F-9257-4637-A041-C5A26DC04503Q35655465-D173DF13-321E-44F8-82E9-6F3AE7C99002Q35706096-040A5F53-A892-4DA1-A160-726BBEC92513Q36466791-129F09C5-1511-43A9-A1DD-524C680E9538Q36707257-F8261822-F28D-45B1-A4CF-4FEAB31E2DE1Q36741453-422C9180-8C10-4C7C-9C42-DAF27D9A0595Q36747165-8F69634B-8E89-427D-BB15-7227FE8B6EECQ36754333-65B71BB5-CD10-4970-986C-CC882AF8F915Q36756875-D156A723-6BBB-4780-A785-623E2AFB48FCQ36821490-28A2341D-4418-4A39-870A-D08ADFE67EA7Q36838661-3B53AF8C-0AA8-45E6-BFD3-DD7027C7D575Q37812384-84DD032A-4C8C-4B24-B80C-C3E6AD13D89AQ38285588-EE944ADC-5A1F-42C9-A08D-C21A750C0FFCQ38652016-96AE4CFE-258E-4BD3-8863-BCCE318B0A34Q38652026-1D42DE5D-9904-4CD8-9876-2036E58ED470Q38951500-07025FC9-3439-469D-938B-59D6DBBE7039Q40086997-738EB630-5516-4747-9A20-92F3DF814092Q41312357-558DF213-25EC-4DC8-AC26-C12CEBED30AAQ41928556-A25D8BA9-EA61-4AE1-98C0-D39B20CE7320Q42339402-6AFB6BDC-4C3C-4724-8535-3AB6E5F4DA6DQ42578888-9D8AFFC8-E906-47DE-BC8B-3B25A00FE291Q46141791-0BE23824-C2AD-463F-8654-A264AF5B34DEQ51128798-932B56D7-C64B-4DFF-814A-AE1174E0AE04Q53489965-BB8DBD12-7BBC-4955-B46F-598FFC69DA7F
P2860
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
@en
type
label
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
@en
prefLabel
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
@en
P2093
P2860
P356
P1476
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
@en
P2093
P2860
P304
P356
10.1136/HRT.46.2.168
P577
1981-08-01T00:00:00Z